Dose Range Finding Trial for Tozorakimab in Adults With Uncontrolled Asthma
Phase 2
540
about 3 years
18–75
51 sites in CA, DE, FL +22
About this study
This trial is testing different doses of tozorakimab, a medication given by injection, in adults with uncontrolled asthma who are already taking medium-to-high doses of inhaled corticosteroids. The goal is to see if these doses are effective and safe.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Placebo
- 2.Take Tozorakimab
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
monoclonal antibody
Secondary: Change from baseline in post-bronchodilator FEV1, Change from baseline in pre-bronchodilator forced expiratory volume in 1 second (FEV1), Change from baseline in the Asthma Control Questionnaire 6 (ACQ-6), Change from baseline in the Asthma Quality of Life Questionnaire for 12 Years and Older (AQLQ12+)
Respiratory